about
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differ...
Read More
13.53
0.19
(1.42%)
13,187
XNAS Volume
XNAS 08 Jul, 2025 10:31 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Celcuity Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..